HSD17B13-IN-79

HSD17B13-IN-79 (Compound 32), an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), demonstrates potent activity with an IC50 value of ≤ 0.1 μM against estradiol. This compound is primarily utilized in the study of liver, metabolic, and cardiovascular diseases, including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and drug-induced liver injury (DILI) [1].